Tacrolimus 0.1% versus ciclopiroxolamine 1% for maintenance therapy in patients with severe facial seborrheic dermatitis : a multicenter, double-blind, randomized controlled study - Supplementary Appendix
Published: 24 September 2020| Version 1 | DOI: 10.17632/y3hmp9nbty.1
Contributors:
Ines TEJEDOR, Pascal JolyDescription
Supplementary Appendix
Files
Categories
Seborrheic Dermatitis